Sais e Derivados de API
Os sais dos Ingredientes Farmacêuticos Ativos (API) são compostos formados pela reação de um ácido com uma base, resultando em um equilíbrio iônico. Esses sais frequentemente melhoram a solubilidade e a estabilidade dos APIs, facilitando sua absorção no organismo. Os derivados de API são variantes químicas de um princípio ativo que podem apresentar propriedades aprimoradas ou modificadas para otimizar a eficácia terapêutica. Os sais de APIs são utilizados na formulação de medicamentos orais, injetáveis e tópicos. Além disso, os derivados de API podem melhorar a farmacocinética dos fármacos, permitindo, por exemplo, a liberação controlada de substâncias ativas.
Na CymitQuimica, oferecemos sais e derivados de APIs com a pureza e qualidade necessárias para pesquisa e desenvolvimento de formulações farmacêuticas.
Foram encontrados 79473 produtos de "Sais e Derivados de API"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Procarbazine Related Compound A (4-Formyl-N-isopropylbenzamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C11H13NO2Cor e Forma:White Yellow SolidPeso molecular:191.09463Vigabatrin Related Compound B ((E)-2-(2-aminoethyl)but-2-enoic acid hydrochloride)
Amino-acids (excluding aromatic) and their esters other than those containing more than one kind of oxygen function, nesoiFórmula:C6H11NO2·HClCor e Forma:White PowderPeso molecular:165.05566Amlodipine Related Compound F (Dimethyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate maleate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C19H23ClN2O5·C4H4O4Cor e Forma:Off-White PowderPeso molecular:510.92 g/molMirtazapine Related Compound D (2-Methyl-1,2,3,4-tetrahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepin-10(14bH)-one)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C17H17N3OCor e Forma:White Pale Yellow SolidPeso molecular:279.13716Tioconazole Related Compound C (1-[2,4-Dichloro-β-[(5-bromo-2-chloro-3-thenyl)-oxy]-phenethyl]imidazole hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C16H12BrCl3N2OS·HClCor e Forma:Off-White PowderPeso molecular:463.89193Amoxicillin Related Compound I ((R)-2-Amino-2-(4-hydroxyphenyl)acetic acid)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFórmula:C8H9NO3Cor e Forma:White Crystalline PowderPeso molecular:167.05824Fentanyl Related Compound D (N-Phenyl-1-(phenylmethyl)-4-piperidinamine)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C18H22N2Cor e Forma:White Yellow PowderPeso molecular:266.1783Fluticasone Propionate Related Compounds Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCor e Forma:PowderSulfaquinoxaline Related Compound A (N1,N2-diquinoxalin-2-ylsulfanilamide)
CAS:Sulfonamides, excluding drugsFórmula:C22H16N6O2SCor e Forma:Orange PowderPeso molecular:428.48Warfarin Related Compound A (3-(o-hydroxyphenyl)-5-phenyl-2-cyclohexen-1-one)
CAS:Ketone-phenols and ketones with other oxygen functionFórmula:C18H16O2Cor e Forma:White Pale Yellow Crystals NeedlesPeso molecular:264.11503Atenolol Related Compound B (2-[4-(2,3-Dihydroxypropoxy)phenyl]acetamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C11H15NO4Cor e Forma:White PowderPeso molecular:225.10011Irinotecan Related Compound C (11-Ethyl-4-hydroxy-4-methyl-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl (1,4'-bipiperidine)- 1'-carboxylate hydrochloride)
CAS:Vegetable alkaloids, natural or reproduced by synthesis, their salts and other derivatives, nesoiFórmula:C32H36N4O6·HClCor e Forma:Yellow PowderPeso molecular:608.24016Pioglitazone Hydrochloride
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFórmula:C19H20N2O3S·HClCor e Forma:White PowderPeso molecular:356.11946Flumazenil Related Compound C (N,N-Dimethylformamide diethyl acetal)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFórmula:C7H17NO2Cor e Forma:Colorless Light Yellow LiquidPeso molecular:147.12593Aminocaproic Acid Related Compound B (6-[6-(6-Aminohexanamido)hexanamido]hexanoic acid)
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFórmula:C18H35N3O4Cor e Forma:White SolidPeso molecular:357.26276Tropicamide Related Compound B (N-ethyl-2-phenyl-N-(pyridin-4-ylmethyl)acrylamide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C17H18N2OCor e Forma:Brown LiquidPeso molecular:266.14191Bisacodyl Related Compound E (2-[(4-Acetoxyphenyl)(pyridin-2-yl)methyl]phenyl acetate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C22H19NO4Cor e Forma:White Off-White PowderPeso molecular:361.13141Levofloxacin Related Compound B ((S)-9,10,difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C13H9F2NO4Cor e Forma:White Off-White Crystalline PowderPeso molecular:281.04996Nicotine Related Compound A (1,2,3,6-tetrahydro-2,3'-bipyridine)
CAS:Vegetable alkaloids, natural or reproduced by synthesis, their salts and other derivatives, nesoiFórmula:C10H12N2Cor e Forma:Pale Yellow Light Brown LiquidPeso molecular:160.10005Nebivolol Related Compound B (See USP Certificate for full Chemical Name)
Aromatic pesticides with oxygen heteroFórmula:C22H25F2NO4·HClCor e Forma:PowderPeso molecular:441.9Sulconazole Related Compound A (1-[2-(4-Chlorobenzyl)sulfinyl-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole nitrate)
CAS:Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFórmula:C18H15Cl3N2OS·HNO3Cor e Forma:PowderPeso molecular:474.99271Tiagabine Isomer (1-(4,4-Bis(4-methylthiophen-2-yl)but-3-en-1-yl)piperidine-3-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C20H25NO2S2Cor e Forma:Brown SolidPeso molecular:375.13267Verapamil Related Compound F ((3,4-Dimethoxyphenyl)methanol)
CAS:Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFórmula:C9H12O3Cor e Forma:Colorless Light Yellow Clear Liquid ViscousPeso molecular:168.078646-Ketonorethindrone Acetate (3,6-Dioxo-19-nor-17α pregn-4-en-20-yn-17-yl acetate)
CAS:Carboxylic acids with aldehyde or ketone function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids andtheir derivFórmula:C22H26O4Cor e Forma:Light Yellow PowderPeso molecular:354.45Alprazolam Related Compound A (2-(2-acetylhydrazino)-7-chloro-5-phenyl-3H-1,4-benzodiazepine)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C17H15ClN4OCor e Forma:White PowderPeso molecular:326.09344Oxymetazoline Related Compound A (N-(2-Aminoethyl)-2-[4-(tert-butyl)-3-hydroxy-2,6-dimethylphenyl]acetamide hydrochloride)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C16H26N2O2·HClCor e Forma:White Off-White PowderPeso molecular:314.176111,2-Dinitroglycerin
CAS:Esters of other inorganic acids of nonmetals & their salts, their halogenated/sulfonated/nitrated/nitrosated derivs, except of hydrogen halides, nesoiFórmula:C3H6N2O7Cor e Forma:Clear Colorless LiquidPeso molecular:182.0175Palonosetron Related Compound E (2-[(3S)-Quinuclidin-3-yl]-2,4,5,6-tetrahydro-1H-benzo[de]isoquinolin-1-one hydrochloride)
CAS:Lactams, nesoiFórmula:C19H22N2O·HClCor e Forma:Yellow SolidPeso molecular:330.852-Amino-5-chlorobenzophenone
CAS:Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFórmula:C13H10ClNOCor e Forma:Yellow Crystalline PowderPeso molecular:231.04509Desogestrel Related Compound C (13-Ethyl-11-methylene-18,19-dinor-17α-pregn-4-en-20-yn-17-ol-3-one)
CAS:Estrogens and progestinsFórmula:C22H28O2Cor e Forma:White Crystalline PowderPeso molecular:324.20893Olmesartan Medoxomil Related Compound A (1-{[2'-(1H-Tetrazol-5-yl)biphenyl-4-yl]methyl}-4,4-dimethyl-2-propyl-1H-furo[3,4-d]imidazol-6(4H)-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C24H24N6O2Cor e Forma:White SolidPeso molecular:428.19607Ecamsule Related Compound E (Sodium ((1SR,4SR,E)-3-(4-(hydroxymethyl)benzylidene)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate)
CAS:Ketones and quinones, w/not with other oxygen function,and their halogenated,sulfated,nitrated,or nitrosated derivatives, nesoiFórmula:C18H21NaO5SCor e Forma:White PowderPeso molecular:372.41Valproic Acid Related Compound A (2-allylpent-4-enoic acid)
CAS:Unsaturated acyclic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives, nesoiFórmula:C8H12O2Cor e Forma:Clear LiquidPeso molecular:140.08373Nifedipine Nitrophenylpyridine Analog (Dimethyl 4-(2-nitrophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C17H16N2O6Cor e Forma:White Yellow PowderPeso molecular:344.10084Rufinamide Related Compound A (1-(2-Fluorobenzyl)-1H-1,2,3-triazole-4-carboxamide)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C10H9FN4OCor e Forma:White PowderPeso molecular:220.07604Benazepril Related Compound F (tert-Butyl-3-amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid)
CAS:Lactams not elsewhere specified or includedFórmula:C16H22N2O3Cor e Forma:White Off-White Crystalline PowderPeso molecular:290.36Ibutilide Related Compound B (N-Ethyl-N-heptyl-4-hydroxy-4-[4-(methylsulfonamido)phenyl]butanamide)
CAS:Sulfonamides, nesoiFórmula:C20H34N2O4SCor e Forma:White Off-White PowderPeso molecular:398.22393Almotriptan Related Compound D (1-[({3-[2-(dimethylamino)ethyl]indol-5-yl}methyl)sulfonyl]pyrrolidine N-oxide hydrochloride)
CAS:Aromatic or modified aromatic drugs with nitrogen heteroFórmula:C17H25N3O3SCor e Forma:PowderPeso molecular:351.16166Apixaban Related Compound D (N-Formyl-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide)
CAS:Lactams, nesoiFórmula:C26H25N5O5Cor e Forma:White Off-White PowderPeso molecular:487.18557Amoxicillin Related Compound H ((R)-2-(4-hydroxyphenyl)-2-pivalamidoacetic acid)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFórmula:C13H17NO4Cor e Forma:Off-White PowderPeso molecular:251.28Roflumilast Related Compound D (3-(Cyclopropylmethoxy)-4-(difluoromethoxy)benzoic acid)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFórmula:C12H12F2O4Cor e Forma:Yellow White PowderPeso molecular:258.07037Norfloxacin Related Compound E (7-Chloro-1-ethyl-4-oxo-6-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C16H18ClN3O3Cor e Forma:Off-White SolidPeso molecular:335.10367Oxybutynin Related Compound C (4-(ethylmethylamino)but-2-ynyl(+/-)-2-cyclohexyl-2-hydroxy-2-phenylacetate hydrochloride)
Amino-alcohols, other than those containing more than oFórmula:C21H30ClNO3Cor e Forma:White PowderPeso molecular:379.92Oxacillin Related Compound C (5-Methyl-3-phenylisoxazole-4-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C11H9NO3Cor e Forma:Off-White PowderPeso molecular:203.05824Formoterol Related Compound C (N-(2-Hydroxy-5-(1-hydroxy-2-{[1-(4-methoxyphenyl)propan-2-yl]amino}ethyl)phenyl)acetamide fumarate)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:(C20H26N2O4)2·C4H4O4Cor e Forma:Off-White Light Brown SolidPeso molecular:832.95Valacyclovir Related Compound C (2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-methyl-L-valinate hydrochloride)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C14H22N6O4·HClCor e Forma:White PowderPeso molecular:338.17025Citalopram Related Compound A (1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carboxamide)
CAS:Aromatic pesticides with oxygen hetero-atom(s) only neFórmula:C20H23FN2O2Cor e Forma:Cream PowderPeso molecular:342.17436Calcipotriene Related Compound C ((5E,7E,22E,24S)-24-Cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1α,3β,24-triol)
CAS:Other cyclanic, cyclenic or cycloterpenic alcohols and their halogenated, sulfonated, nitrated or nitrosated derivativesFórmula:C27H40O3Cor e Forma:PowderPeso molecular:412.297755-Amino-2,4,6-triiodo-N-methylisophthalamic Acid
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C9H7I3N2O3Cor e Forma:White PowderPeso molecular:571.75908Ibuprofen Related Compound J (2-(4-Isobutyrylphenyl)propanoic acid)
CAS:Aromatic polycarboxylic acids, their anhydrides, halides, peroxides, peroxyacids etc not elsewhere specified or includedFórmula:C13H16O3Cor e Forma:Brown SolidPeso molecular:220.10994Trihexyphenidyl Related Compound A (1-Phenyl-3-(piperidin-1-yl)propan-1-one hydrochloride)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C14H19NO·HClCor e Forma:SolidPeso molecular:253.12334Selegiline Related Compound D ((R)-N-(1-Phenylpropan-2-yl)prop-2-yn-1-amine hydrochloride)
CAS:Aromatic monoamines and their derivatives, salts thereof, nesoiFórmula:C12H15N·HClCor e Forma:White Off-White PowderPeso molecular:209.09713Vigabatrin Related Compound A (5-vinylpyrrolidin-2-one)
CAS:Amino-acids (excluding aromatic) and their esters other than those containing more than one kind of oxygen function, nesoiFórmula:C6H9NOCor e Forma:Clear Colorless Reddish-Brown LiquidPeso molecular:111.06841Sodium Picosulfate Related Compound A (4-[(Pyridin-2-yl)(4-hydroxyphenyl)methyl]phenyl sodium sulfate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C18H14NNaO5SCor e Forma:White PowderPeso molecular:379.04904Travoprost
CAS:Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analoguesFórmula:C26H35F3O6Cor e Forma:Colorless Clear Pale Yellow LiquidPeso molecular:500.23857Aripiprazole Related Compound C (1-(2,3-dichlorophenyl)piperazine hydrochloride)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C10H12Cl2N2·HClCor e Forma:White PowderPeso molecular:267.58Rivaroxaban Open Chain Dithiophene Analog ((S)-5-chloro-N-(4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)-N-(2-(2-(methylamino)-2-oxoethoxy)ethyl)thiophene-2-carboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C25H24Cl2N4O6S2Cor e Forma:White Off-White SolidPeso molecular:610.05143Rivaroxaban Open Ring S-isomer ((S)-5-chloro-N-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)thiophene-2-carboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C18H20ClN3O4SCor e Forma:White Off-White SolidPeso molecular:409.0863Cetirizine Related Compound A ((RS)-2-[2-[4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetic acid ethyl ester oxalate)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C25H31ClN2O7Cor e Forma:White PowderPeso molecular:506.98Ecamsule Related Compound D (((1SR,4RS)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid)
CAS:Halogenated, sulfonated, nitrated or nitrosated derivatFórmula:C10H16O4SCor e Forma:White Beige PowderPeso molecular:232.07693Dofetilide Related Compound A (N-[4-(2-{2-[4-(Methanesulfonamido)phenoxy]ethylamino}ethyl)phenyl]methanesulfonamide)
CAS:Sulfonamides, nesoiFórmula:C18H25N3O5S2Cor e Forma:White PowderPeso molecular:427.54Vecuronium Bromide Related Compound B (Piperidinium, 1-[(2β, 3α, 5α, 16β, 17β)-3-acetyloxy-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C32H55BrN2O3Cor e Forma:Off-White PowderPeso molecular:594.33961Ranolazine Related Compound D (2,2'-(Piperazine-1,4-diyl)bis[N-(2,6-dimethylphenyl)acetamide])
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C24H32N4O2Cor e Forma:White Off-White PowderPeso molecular:408.25253Methotrexate Related Compound B ((S)-2-{4-[(2,4-diaminopteridin-6-yl)methylamino]benzamido}pentanedioic acid)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C19H20N8O5Cor e Forma:White Yellow PowderPeso molecular:440.41Voriconazole Related Compound D ((2RS,3SR)-2-(2,4-difluorophenyl)-3-(pyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFórmula:C16H15F2N5OCor e Forma:White Off-White SolidPeso molecular:331.12447Azathioprine Related Compound G (6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-9H-purin-2-amine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C9H8N8O2SCor e Forma:PowderPeso molecular:292.04909Brimonidine Related Compound B (1-(5-Bromoquinoxalin-6-yl)thiourea)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C9H7BrN4SCor e Forma:White Yellow PowderPeso molecular:283.15Sulfamethoxazole Related Compound A (N-{4-[N-(5-methylisoxazol-3-yl)sulfamoyl]phenyl}acetamide)
CAS:Sulfonamides, nesoiFórmula:C12H13N3O4SCor e Forma:White Crystalline PowderPeso molecular:295.32Orphenadrine Related Compound E (N,N-Dimethyl-2-[phenyl(m-tolyl)methoxy]ethanamine)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFórmula:C18H23NOCor e Forma:Light Yellow LiquidPeso molecular:269.17796Penicillamine Disulfide (3,3'-Dithiodi-D-valine)
CAS:Thioglycolic acid and mercaptocarboxylic acidsFórmula:C10H20N2O4S2Cor e Forma:White PowderPeso molecular:296.08645Rivastigmine Related Compound E ((S)-1-(3-{[Ethyl(methyl)carbamoyl]oxy}phenyl)-N,N,N-trimethylethanaminium chloride)
Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C15H25ClN2O2Cor e Forma:White SolidPeso molecular:300.16046Raltegravir Related Compound E (N-{2-[4-(Benzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]propan-2-yl}-5-methyl-1,3,4-oxadiazole-2-carboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C20H22N6O5Cor e Forma:White PowderPeso molecular:426.16517o-Flutamide
Aromatic cyclic amides (including cyclic carbamates) anFórmula:C11H11F3N2O3Cor e Forma:PowderPeso molecular:276.22Brinzolamide Related Compound B ((R)-4-Amino-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide oxalate)
CAS:Sulfonamides, nesoiFórmula:C10H17N3O5S3·C2H2O4Cor e Forma:Off-White SolidPeso molecular:445.49Ketorolac Related Compound D (5-benzoyl-2,3-dihydro-1H-pyrrolizine)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C14H13NOCor e Forma:White Light Brown PowderPeso molecular:211.09971Terazosin Related Compound B (1-(4-Hydroxy-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C19H24N4O5Cor e Forma:White PowderPeso molecular:388.17467Eszopiclone Related Compound A (6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo [3,4,b] pyrazin-5-yl 4-methylpiperazine-1-carboxylate 4-oxide)
CAS:Lactams not elsewhere specified or includedFórmula:C17H17ClN6O4Cor e Forma:Off-White PowderPeso molecular:404.09998Bisacodyl Related Compound B (2,4'-(Pyridin-2-ylmethylene)diphenol)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C18H15NO2Cor e Forma:White Light Yellow PowderPeso molecular:277.11028Sulfasalazine Related Compound K (5-{4-[N-(6-Methylpyridin-2-yl)sulfamoyl]phenyldiazenyl}salicylic acid)
CAS:Sulfonamides, nesoiFórmula:C19H16N4O5SCor e Forma:Yellow PowderPeso molecular:412.42Hyoscyamine Related Compound A (Norhyoscyamine Sulfate)
Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoiFórmula:(C16H21NO3)2H2SO4Cor e Forma:White PowderPeso molecular:648.77Pancuronium Bromide Related Compound C (1,1'-(3α-acetoxy-17β-hydroxy-5α-androstan-2β,16β-ylene) bis(1-methylpiperidinium) dibromide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C33H58N2O3·2BrCor e Forma:White Crystalline PowderPeso molecular:530.44474Risedronate Related Compound A ([1-Hydroxy-2-(2-pyridinyl)ethylidene]bis(phosphonic acid), monohydrate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C7H11NO7P2·H2OCor e Forma:White Crystalline PowderPeso molecular:301.01164Lumefantrine Related Compound A ((RS, Z)-2-(Dibutylamino)-2-(2,7-dichloro-9-(4-chlorobenzylidene)-9H-fluoren-4-yl)ethanol hydrochloride)
Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFórmula:C30H32Cl3NO·HClCor e Forma:Yellow PowderPeso molecular:527.15495Dimenhydrinate Related Compound E (8-chloro-3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione)
CAS:Vegetable alkaloids, natural or reproduced by synthesis, their salts and other derivatives, nesoiFórmula:C8H9ClN4O2Cor e Forma:White Off-White PowderPeso molecular:228.0414Bendamustine Related Compound A (4-{5-[Bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid hydrochloride)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C16H23N3O4HClCor e Forma:White SolidPeso molecular:357.83Clonidine Related Compound B (2-[(E)-2,6-dichlorophenylimino]-1-(1-{2-[(E)-2,6-dichlorophenylimino]-imidazolidin-1-yl}-ethyl)-imidazolidine)
CAS:Compounds containing an unfused imidazole ring (whetherFórmula:C20H20Cl4N6Cor e Forma:White Off-White PowderPeso molecular:486.23Prochlorperazine Related Compound A (4-Chloro-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine dihydrochloride)
CAS:Compounds (excluding drugs) containing a phenothiazine ring-system (whether or not hydrogenated), not further fusedFórmula:C20H24ClN3S·2HClCor e Forma:Light Grey PowderPeso molecular:373.13795Acamprosate Related Compound A (3-aminopropane-1-sulfonic acid)
CAS:Acyclic monoamines and their derivatives, nesoiFórmula:C3H9NO3SCor e Forma:PowderPeso molecular:139.17Apixaban Related Compound G (Ethyl 6-[4-(5-bromopentanamido)phenyl]-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate)
CAS:Lactams, nesoiFórmula:C27H29BrN4O5Cor e Forma:Cream PowderPeso molecular:568.13213Allopurinol Related Compound B (5-(formylamino)-1H-pyrazole-4-carboxamide)
CAS:Compounds containing an unfused pyrazole ring, whether or not hydrogenated, in the structure, nesoiFórmula:C5H6N4O2Cor e Forma:White PowderPeso molecular:154.04908Amlodipine Related Compound B (3-Ethyl 5-methyl 4-(2-chlorophenyl)-6-methyl-2-({2-[2-(methylcarbamoyl)benzamido]ethoxy}methyl)-1,4-dihydropyridine-3,5-dicarboxylate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C29H32ClN3O7Cor e Forma:White PowderPeso molecular:569.19288Orphenadrine Related Compound A ((RS)-N,N-dimethyl-2-[(3-methylphenyl)-phenylmethoxy]ethanamine citrate) (AS)
Amino-alcohols, other than those containing more than oFórmula:C18H23NO·C6H8O7Cor e Forma:White Crystalline PowderPeso molecular:461.5Dantrolene Related Compound B (5-(4-nitrophenyl)-2-furaldehyde-(2-carboxymethyl) semicarbazone)
CAS:Compounds containing an unfused furan ring (whether or not hydrogenated) in the structure nesoiFórmula:C14H12N4O6Cor e Forma:Yellow PowderPeso molecular:332.07568Phentermine Related Compound C ((2-Methylprop-1-en-1-yl)benzene)
CAS:Cyclic hydrocarbons not elsewhere specified or includedFórmula:C10H12Cor e Forma:Colorless LiquidPeso molecular:132.0939Acetyl Simvastatin ((1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-(acetoxy)-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate)
CAS:Lactones, nesoiFórmula:C27H40O6Cor e Forma:PowderPeso molecular:460.28249Allopurinol Related Compound C (5-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4-carboxamide)
CAS:Compounds containing an unfused pyrazole ring, whether or not hydrogenated, in the structure, nesoiFórmula:C6H6N6OCor e Forma:White Off-White Crystalline PowderPeso molecular:178.06031Carteolol Related Compound F (5-(2-Hydroxy-3-methoxypropoxy)-3,4-dihydroquinolin-2(1H)-one)
CAS:Lactams not elsewhere specified or includedFórmula:C13H17NO4Cor e Forma:White Off-White PowderPeso molecular:251.11576Atomoxetine Related Compound C (N-methyl-3-phenyl-3-(p-tolyloxy)propan-1-amine hydrochloride)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFórmula:C17H21NO·HClCor e Forma:Off-White SolidPeso molecular:291.82Cevimeline trans-Isomer ((2RS,2'SR)-2'-Methyl-4-azaspiro{bicyclo[2.2.2]octane-2,5'-[1,3]oxathiolane} hydrochloride hemihydrate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C10H17NOS·HClH2OCor e Forma:White PowderPeso molecular:244.78
![Oxymetazoline Related Compound A (N-(2-Aminoethyl)-2-[4-(tert-butyl)-3-hydroxy-2,6-dimethylphenyl]…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1486015.webp&w=3840&q=75)
![Orphenadrine Related Compound E (N,N-Dimethyl-2-[phenyl(m-tolyl)methoxy]ethanamine)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1479053.webp&w=3840&q=75)
